BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1582589)

  • 81. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.
    Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Increased mucosal synthesis of rheumatoid factor (RF) in coeliac disease.
    Hällgren J; Knutson F; Lavö B; Hällgren R
    Clin Exp Immunol; 1996 Jan; 103(1):94-8. PubMed ID: 8565295
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley.
    Ellis HJ; Doyle AP; Day P; Wieser H; Ciclitira PJ
    Int Arch Allergy Immunol; 1994 Jul; 104(3):308-10. PubMed ID: 7518270
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Animal model of gluten induced enteropathy in mice.
    Troncone R; Ferguson A
    Gut; 1991 Aug; 32(8):871-5. PubMed ID: 1885068
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Studies on the interaction between alpha-gliadin and HLA and T cell receptor molecules in coeliac disease.
    Gallagher RB; Feighery C; Weir DG; Kelly CP; Whelan CA
    Clin Exp Immunol; 1988 Dec; 74(3):413-8. PubMed ID: 3266119
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Preferential activation of CD4 T lymphocytes in the lamina propria of gluten-sensitive enteropathy.
    Griffiths CE; Barrison IG; Leonard JN; Caun K; Valdimarsson H; Fry L
    Clin Exp Immunol; 1988 May; 72(2):280-3. PubMed ID: 3261663
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry.
    Przemioslo RT; Kontakou M; Nobili V; Ciclitira PJ
    Gut; 1994 Oct; 35(10):1398-403. PubMed ID: 7959194
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of gliadin peptides B1-B4 in celiac disease. I. Organ culture studies.
    Stallmach A; Belitz HD; Gellermann B; Schäfer H; Wieser H; Stern M
    J Pediatr Gastroenterol Nutr; 1987; 6(3):335-40. PubMed ID: 3430242
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Increased HLA-DR expression by enterocytes in children with celiac disease.
    Arnaud-Battandier F; Cerf-Bensussan N; Amsellem R; Schmitz J
    Gastroenterology; 1986 Nov; 91(5):1206-12. PubMed ID: 3758613
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.
    Cornell HJ; Maxwell RJ
    Clin Chim Acta; 1982 Aug; 123(3):311-9. PubMed ID: 6811164
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immune response of the coeliac nasal mucosa to locally-instilled gliadin.
    Torre P; Fusco S; Quaglia F; La Rotonda ML; Paparo F; Maglio M; Troncone R; Greco L
    Clin Exp Immunol; 2002 Mar; 127(3):513-8. PubMed ID: 11966769
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture.
    Shidrawi RG; Day P; Przemioslo R; Ellis HJ; Nelufer JM; Ciclitira PJ
    Scand J Gastroenterol; 1995 Aug; 30(8):758-63. PubMed ID: 7481543
    [TBL] [Abstract][Full Text] [Related]  

  • 93. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
    de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
    Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Protein synthesis by cultured jejunal mucosa from control subjects and patients with coeliac disease.
    Jones PE; L'Hirondel CL; Peters TJ
    Gut; 1981 Aug; 22(8):623-7. PubMed ID: 7286778
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Toxicity of different wheat gliadins in coeliac disease.
    Wieser H; Springer G; Belitz HD; Ashkenazi A; Idar D
    Z Lebensm Unters Forsch; 1982; 175(5):321-6. PubMed ID: 6758408
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Coeliac activity of the gliadin peptides CT-1 and CT-2.
    Wieser H; Belitz HD; Idar D; Ashkenazi A
    Z Lebensm Unters Forsch; 1986 Feb; 182(2):115-7. PubMed ID: 3705771
    [TBL] [Abstract][Full Text] [Related]  

  • 97. In vitro hydrolysis of gliadin and casein peptides: secondary defect in coeliac disease shown by organ culture.
    Walz F; Wieser H; Stern M
    Scand J Gastroenterol; 1996 Mar; 31(3):240-6. PubMed ID: 8833353
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Studies of in vitro gamma-interferon production in coeliac disease as a response to gliadin peptides.
    Cornell HJ; Skerritt JH; Puy R; Javadpour M
    Biochim Biophys Acta; 1994 May; 1226(2):126-30. PubMed ID: 8204658
    [TBL] [Abstract][Full Text] [Related]  

  • 99. FAS engagement drives apoptosis of enterocytes of coeliac patients.
    Maiuri L; Ciacci C; Raia V; Vacca L; Ricciardelli I; Raimondi F; Auricchio S; Quaratino S; Londei M
    Gut; 2001 Mar; 48(3):418-24. PubMed ID: 11171836
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of gliadin-derived peptides from bread and durum wheats on in vitro cultures of human cell lines. Implications for coeliac disease pathogenesis.
    Rocca E; Paganuzzi Stammati A; Zampaglioni F; Zucco F
    Toxicol Lett; 1983 May; 16(3-4):331-8. PubMed ID: 6857727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.